Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ... Imperial College London, 2020 | 5302 | 2020 |
Estimates of the severity of coronavirus disease 2019: a model-based analysis R Verity, LC Okell, I Dorigatti, P Winskill, C Whittaker, N Imai, ... The Lancet infectious diseases 20 (6), 669-677, 2020 | 4805 | 2020 |
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ... Nature 584 (7820), 257-261, 2020 | 3702 | 2020 |
Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 1746* | 2021 |
The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ... Science 369 (6502), 413-422, 2020 | 1657* | 2020 |
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ E Lavezzo, E Franchin, C Ciavarella, G Cuomo-Dannenburg, L Barzon, ... Nature 584 (7821), 425-429, 2020 | 1387* | 2020 |
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ... The Lancet global health 8 (9), e1132-e1141, 2020 | 907* | 2020 |
Reduction in mobility and COVID-19 transmission P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ... Nature communications 12 (1), 1-9, 2021 | 588 | 2021 |
Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries S Flaxman, S Mishra, A Gandy, HJT Unwin, H Coupland, TA Mellan, ... Imperial College London 10, 77731, 2020 | 532 | 2020 |
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ... The Lancet Infectious Diseases 20 (12), 1381-1389, 2020 | 260* | 2020 |
Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study X Li, C Mukandavire, ZM Cucunubá, SE Londono, K Abbas, HE Clapham, ... The Lancet 397 (10272), 398-408, 2021 | 230 | 2021 |
Response to COVID-19 in South Korea and implications for lifting stringent interventions A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ... BMC medicine 18, 1-12, 2020 | 207 | 2020 |
State-level tracking of COVID-19 in the United States HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ... Nature communications 11 (1), 6189, 2020 | 179 | 2020 |
Report 21: Estimating COVID-19 cases and reproduction number in Brazil TA Mellan, HH Hoeltgebaum, S Mishra, C Whittaker, RP Schnekenberg, ... | 162* | 2020 |
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study R Sonabend, LK Whittles, N Imai, PN Perez-Guzman, ES Knock, ... The Lancet 398 (10313), 1825-1835, 2021 | 161 | 2021 |
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis AB Hogan, P Winskill, OJ Watson, PGT Walker, C Whittaker, M Baguelin, ... Vaccine 39 (22), 2995-3006, 2021 | 153* | 2021 |
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment KEC Ainslie, CE Walters, H Fu, S Bhatia, H Wang, X Xi, M Baguelin, ... Wellcome Open Research 5, 2020 | 149 | 2020 |
Adoption and impact of non-pharmaceutical interventions for COVID-19 N Imai, KAM Gaythorpe, S Abbott, S Bhatia, S van Elsland, K Prem, Y Liu, ... Wellcome open research 5, 2020 | 145 | 2020 |
Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England ES Knock, LK Whittles, JA Lees, PN Perez-Guzman, R Verity, RG FitzJohn, ... Science Translational Medicine 13 (602), eabg4262, 2021 | 128* | 2021 |
COVID-19 Genomics UK (COG-UK) consortium. Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 127 | 2021 |